Jun 13
Athens Ciné Athens, GA
TicketsJonathan Eggenschwiler, Ph.D.
Associate Professor in the Department of Genetics at the University of Georgia
moderated byMorgane Golan, Ph.D.
Educator, Postdoctoral Associate, University of Georgia
The Time Traveler's Wife— Jeans Through Time: Genetics, Fate and the Physics of Love
Program Description
The discussion and Q&A will be centered around genetics, physics, clinical psychology (grief), as well as cell fate, and the physics of love. We will have 3D Printing on site of a 3D DNA Fidget toy as well as Rec Room Books highlighting Audrey Niffenegger book titles. We will have a surprise book give-away as well as surprise fidget give-aways.
Film Synopsis
A librarian possesses a unique gene that lets him involuntarily travel through time. His wife finds it difficult to cope with it.
The Time Traveler’s Wife follows Henry DeTamble (Eric Bana), a Chicago librarian with a rare genetic disorder that involuntarily propels him through time. His unpredictable disappearances and sudden reappearances complicate his relationship with Clare Abshire (Rachel McAdams), an artist who has loved him since childhood. Despite the terrifying nature of his jumps and the strain they place on their marriage, the couple fights to build a life together and start a family, making profound sacrifices to navigate a love that transcends the boundaries of time.
Photo credit: New Line Cinema
About the Speaker
Jonathan Eggenschwiler, Ph.D., is an Associate Professor in the Department of Genetics at the University of Georgia. He specializes in mammalian developmental genetics, neuroscience, and molecular biology. Dr. Eggenschwiler’s research focuses on cell fate – the genetic mechanisms guiding embryonic development and the regulation of key cellular communication paths.
Dr. Morgane Golan is an award-winning educator and postdoctoral associate specializing in regenerative biology and medicine at the University of Georgia. Dr. Golan recently earned her Ph.D. in Regenerative Bioscience, and her doctoral research focused on optimizing a stem cell-derived therapeutic to create more accessible treatments for brain injury and neurodegenerative diseases.